Canada - English - Health Canada

cellchem pharmaceuticals inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists

Canada - English - Health Canada

jamp pharma corporation - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists

Canada - English - Health Canada

pharmavite laboratories (1987) inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 325mg; 16mg; 8mg - acetylsalicylic acid 325mg; caffeine 16mg; codeine phosphate 8mg - salicylates

Canada - English - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - codeine (codeine phosphate); acetylsalicylic acid; caffeine - tablet - 8mg; 375mg; 15mg - codeine (codeine phosphate) 8mg; acetylsalicylic acid 375mg; caffeine 15mg - salicylates

European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Canada - English - Health Canada

canapharm manufacturing inc - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 325mg; 15mg; 8mg - acetylsalicylic acid 325mg; caffeine 15mg; codeine phosphate 8mg - salicylates

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - acetylsalicylic acid codeine phosphate… - tablet - acetylsalicylic acid codeine phosphate… - opioid analgesics: natural opium alkaloids

European Union - English - EMA (European Medicines Agency)

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Canada - English - Health Canada

pendopharm division of pharmascience inc - acetylsalicylic acid; caffeine (caffeine citrate); codeine phosphate - tablet - 375mg; 30mg; 15mg - acetylsalicylic acid 375mg; caffeine (caffeine citrate) 30mg; codeine phosphate 15mg - salicylates

Canada - English - Health Canada

pendopharm division of pharmascience inc - acetylsalicylic acid; caffeine (caffeine citrate); codeine phosphate - tablet - 375mg; 15mg; 30mg - acetylsalicylic acid 375mg; caffeine (caffeine citrate) 15mg; codeine phosphate 30mg - opiate agonists